Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 6,547 | 0.0% | 98,151 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 1,011 | 0.0% | 63,999 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 837 | 0.0% | 65,685 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,600 | 0.0% | 138,294 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,751 | 0.0% | 142,040 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,877 | 0.0% | 149,156 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 4,218 | 0.0% | 147,479 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,875 | 0.0% | 126,638 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 3,490 | 0.0% | 129,887 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 4,202 | 0.0% | 117,833 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 3,100 | 0.0% | 122,032 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 5,008 | 0.0% | 123,483 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 4,094 | 0.0% | 123,876 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 4,484 | 0.0% | 127,362 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 5,909 | 0.0% | 128,481 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 11,070 | 0.0% | 166,967 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 10,607 | 0.0% | 169,908 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 13,975 | 0.0% | 168,740 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 11,384 | 0.0% | 171,673 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 13,916 | 0.0% | 181,369 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 8,170 | 0.0% | 189,743 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 8,260 | 0.0% | 193,891 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 5,855 | 0.0% | 203,513 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 12,291 | 0.0% | 193,774 | 12/31/2019 |